Silver Book Fact

Deep Brain Stimulation for Parkinson’s Adds QALYs and Saves Money

Fact image

Pietzsch J, Garner A, Marks W. Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States. Neuromodulation. 2016; 19(7). https://onlinelibrary.wiley.com/doi/abs/10.1111/ner.12474

Reference

Title
Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States
Publication
Neuromodulation
Publication Date
2016
Authors
Pietzsch J, Garner A, Marks W
Volume & Issue
Volume 19, Issue 7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value

Related Facts

  • Impact of Slowed Progression on Severe Stage, Americans Age 65 and Older with Alzheimer’s, 2010-2050  
  • It is imperative to weigh costs of implementing new technologies for predicting onset of Alzheimer’s disease through biomarkers and delaying onset earlier against the potential benefits of improving health. Overall…  
  • Impact of Slowed Progression by Stage of Disease, Americans Age 65 and Older with Alzheimer’s Disease, 2050  
  • A clinical trial in Europe found that treating Alzheimer’s patients with an Alzheimer’s drug reduced annual treatment costs by $1,000 per patient.  
  • Americans Age 65 and Older with Alzheimer’s Disease, 2010–2050